Ascaris exposure and its association with lung function, asthma, and DNA methylation in Northern Europe
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Ascaris infections, with a worldwide prevalence above 10%, can cause respiratory pathology. However, long-term effects on lung function in humans are largely unknown.
OBJECTIVE: We investigated the associations of Ascaris exposure with lung function, asthma, and DNA methylation.
METHODS: Serum Ascaris IgG antibodies were measured in 671 adults aged 18 to 47 years (46% women) from Aarhus, Bergen, and Tartu RHINESSA study centers. Seropositivity was defined as IgG above the 90th percentile. Linear and logistic regressions were used to analyze Ascaris seropositivity as associated with lung function and asthma, adjusted for age, height, and smoking and clustered by center. DNA methylation in blood was profiled by a commercial methylation assay.
RESULTS: Ascaris seropositivity was associated with lower FEV1 (-247 mL; 95% CI, -460, -34) and higher odds for asthma (adjusted odds ratio, 5.84; 95% CI, 1.67, 20.37) among men but not women, also after further adjusting for house dust mite sensitivity, consistent across study centers. At a genome-wide level, Ascaris exposure was associated with 23 differentially methylated sites in men and 3 in women. We identified hypermethylation of the MYBPC1 gene, which can regulate airway muscle contraction. We also identified genes linked to asthma pathogenesis such as CRHR1 and GRK1, as well as a differentially methylated region in the PRSS22 gene linked to nematode infection.
CONCLUSION: Ascaris exposure was associated with substantially lower lung function and increased asthma risk among men. Seropositive participants had sex-specific differences in DNA methylation compared to the unexposed, thus suggesting that exposure may lead to sex-specific epigenetic changes associated with lung pathology.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:149 |
|---|---|
| Enthalten in: |
The Journal of allergy and clinical immunology - 149(2022), 6 vom: 05. Juni, Seite 1960-1969 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jõgi, Nils O [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ascaris |
|---|
| Anmerkungen: |
Date Completed 08.06.2022 Date Revised 19.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaci.2021.11.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335319114 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335319114 | ||
| 003 | DE-627 | ||
| 005 | 20231225225545.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaci.2021.11.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1117.xml |
| 035 | |a (DE-627)NLM335319114 | ||
| 035 | |a (NLM)34996616 | ||
| 035 | |a (PII)S0091-6749(21)01797-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jõgi, Nils O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ascaris exposure and its association with lung function, asthma, and DNA methylation in Northern Europe |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2022 | ||
| 500 | |a Date Revised 19.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Ascaris infections, with a worldwide prevalence above 10%, can cause respiratory pathology. However, long-term effects on lung function in humans are largely unknown | ||
| 520 | |a OBJECTIVE: We investigated the associations of Ascaris exposure with lung function, asthma, and DNA methylation | ||
| 520 | |a METHODS: Serum Ascaris IgG antibodies were measured in 671 adults aged 18 to 47 years (46% women) from Aarhus, Bergen, and Tartu RHINESSA study centers. Seropositivity was defined as IgG above the 90th percentile. Linear and logistic regressions were used to analyze Ascaris seropositivity as associated with lung function and asthma, adjusted for age, height, and smoking and clustered by center. DNA methylation in blood was profiled by a commercial methylation assay | ||
| 520 | |a RESULTS: Ascaris seropositivity was associated with lower FEV1 (-247 mL; 95% CI, -460, -34) and higher odds for asthma (adjusted odds ratio, 5.84; 95% CI, 1.67, 20.37) among men but not women, also after further adjusting for house dust mite sensitivity, consistent across study centers. At a genome-wide level, Ascaris exposure was associated with 23 differentially methylated sites in men and 3 in women. We identified hypermethylation of the MYBPC1 gene, which can regulate airway muscle contraction. We also identified genes linked to asthma pathogenesis such as CRHR1 and GRK1, as well as a differentially methylated region in the PRSS22 gene linked to nematode infection | ||
| 520 | |a CONCLUSION: Ascaris exposure was associated with substantially lower lung function and increased asthma risk among men. Seropositive participants had sex-specific differences in DNA methylation compared to the unexposed, thus suggesting that exposure may lead to sex-specific epigenetic changes associated with lung pathology | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Ascaris | |
| 650 | 4 | |a DNA methylation | |
| 650 | 4 | |a EWAS | |
| 650 | 4 | |a RHINESSA | |
| 650 | 4 | |a asthma | |
| 650 | 4 | |a helminth | |
| 650 | 4 | |a lung function | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 700 | 1 | |a Kitaba, Negusse |e verfasserin |4 aut | |
| 700 | 1 | |a Storaas, Torgeir |e verfasserin |4 aut | |
| 700 | 1 | |a Schlünssen, Vivi |e verfasserin |4 aut | |
| 700 | 1 | |a Triebner, Kai |e verfasserin |4 aut | |
| 700 | 1 | |a Holloway, John W |e verfasserin |4 aut | |
| 700 | 1 | |a Horsnell, William G C |e verfasserin |4 aut | |
| 700 | 1 | |a Svanes, Cecilie |e verfasserin |4 aut | |
| 700 | 1 | |a Bertelsen, Randi J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of allergy and clinical immunology |d 1971 |g 149(2022), 6 vom: 05. Juni, Seite 1960-1969 |w (DE-627)NLM000018449 |x 1097-6825 |7 nnns |
| 773 | 1 | 8 | |g volume:149 |g year:2022 |g number:6 |g day:05 |g month:06 |g pages:1960-1969 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaci.2021.11.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 149 |j 2022 |e 6 |b 05 |c 06 |h 1960-1969 | ||